• No results found

Revealing the complex nature of amyloid beta and its relation to dementia

N/A
N/A
Protected

Academic year: 2021

Share "Revealing the complex nature of amyloid beta and its relation to dementia"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

DOCTORAL THESIS

SAHLGRENSKA ACADEMY

2020

Revealing the complex nature of amyloid beta and its relation to dementia

Eleni Gkanatsiou

Eleni holds a BSc in Biochemistry and

Biotechnology from the University of Thessaly, Greece. Driven by her passion for protein science, she moved to Sweden to obtain an MSc in Applied Biotechnology at Uppsala University.

During her MSc, she fell in love w

ISBN 978-91-8009-060-5 (PRINT) ISBN 978-91-8009-061-2 (PDF) http://hdl.handle.net/2077/65140 Printed by Stema Specialtryck AB, Borås

Revealing the complex nature of amyloid beta and its relation to dementia | Eleni Gkanatsiou

SAHLGRENSKA ACADEMY

INSTITUTE OF NEUROSCIENCE AND PHYSIOLOGY

Revealing the complex nature of amyloid beta and its relation to dementia

Alzheimer disease (AD) is the most common type of dementia and characterized by the accumulation of amyloid plaques in the extracellular space of the brain parenchyma. Amyloid plaques consist of amyloid beta peptides (Aβ). Amyloid pathology can also be involved in other types of dementia, either as a driving force or as a coexisting pathology. In this thesis was investigated the Aβ peptide content in different amyloid deposits, types of dementia and regions, with the goal to improve our understanding of amyloid pathology in dementia. The studies presented here reveal a different Aβ peptide pattern in individuals with amyloid pathology, but cognitively unaffected, compared with AD patients, who suffer from cognitive decline.

Moreover, vascular Aβ contribution, due to cerebral amyloid angiopathy, differs from amyloid plaque Aβ contribution. For other groups with plaque pathology, such as Down syndrome, dementia with Lewy bodies, and Parkinson’s disease dementia, there are minor differences in the Aβ

peptide pattern compared with AD. In this work, the Aβ content of the protofibril/oligomeric forms, a major anti-amyloid therapeutical target, is also revealed. This thesis can be the beginning of a deeper understanding of the complex nature of amyloid pathology and its contribution to dementia.

References

Related documents

Epigenetic mechanisms cause heritable changes in gene expression primarily through reversible changes in DNA methylation and remodelling of chromatin structure.. Numerous repeating

Kinetic analysis of fibril formation using SPR In analogy to all molecular interactions, the stability of the binding between an Ab monomer and the fibril- lar end is dependent on

Amyloid pathology can also be involved in other types of dementia, either as a putative driving force, as in cerebral amyloid angiopathy (CAA), Down syndrome (DS) and familial

Keywords: Amyloid beta, dementia, Alzheimer’s disease, cerebral amyloid angiopathy, Down syndrome, pathological ageing, dementia with Lewy bodies, Parkinson’s disease

Using a sensitive marker for neutrophil activation in peripheral blood, endogenous SAA in circulation lacked proinflammatory activity and thus differed functionally from

Escaping the membrane involves a structural transition of the Aβ-peptide from the membrane-bound α-helical secondary structure to the mainly un- structured solution state

Our results demonstrate reduced propagation properties of Aβ aggregated in the presence of Aβ-seeds formed together with p-FTAA compared to Aβ-seeds formed without

1532, 2016 Department of Clinical and Experimental Medicine.